Which has grown faster, LIVN or RLAY?

Over the past five years, LIVN grew revenue faster — LIVN at a 7.57% CAGR versus RLAY at -34.29%.

Is LIVN or RLAY more profitable?

LIVN runs the higher net margin — LIVN at 12.82% versus RLAY at -2763.64%.

How have LIVN and RLAY total returns compared?

Over the past 5 years, LIVN delivered -1.66% and RLAY delivered -7.92% annualized total return. Past performance doesn't predict future results.

LivaNova PLC (LIVN) vs Relay Therapeutics, Inc. (RLAY)

A side-by-side comparison of LivaNova PLC and Relay Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LIVN

LivaNova PLC

$4.14B

$75.42HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

RLAY

Relay Therapeutics, Inc.

$4.00B

$18.27HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

Total return — LIVN vs RLAY

growth of $100 · dividends reinvested · last 6y

LIVN +45.1% (+6.4%/yr)RLAY -44.7% (-9.4%/yr)LIVN compounded faster over this window

LIVN RLAY

LIVN vs RLAY: by the numbers

•LIVN is the larger company ($4.14B vs $4.00B market cap).
•LIVN is profitable (12.82% net margin) while RLAY runs a net loss (-2763.64%).
•LIVN grew revenue faster over the past five years (7.57% vs -34.29% CAGR).

Metrics side by side

Valuation

Metric	LIVN	RLAY
P/E ratio	22.25	N/A
Forward P/E	17.32	N/A
P/S ratio	2.82	386.79
P/B ratio	3.13	4.50
EV / EBITDA	16.28	N/A
FCF yield	3.58%	N/A

Profitability

Metric	LIVN	RLAY
Gross margin	68.18%	76.83%
Operating margin	13.48%	-1971.59%
Net margin	12.82%	-2763.64%
ROE	14.23%	-32.14%
ROIC	10.24%	-33.87%

Growth (annualized)

Metric	LIVN	RLAY
Revenue CAGR (5Y)	7.57%	-34.29%
FCF CAGR (5Y)	20.23%	N/A
Total return CAGR (5Y)	-1.66%	-7.92%

Frequently asked

Which has grown faster, LIVN or RLAY?: Over the past five years, LIVN grew revenue faster — LIVN at a 7.57% CAGR versus RLAY at -34.29%.
Is LIVN or RLAY more profitable?: LIVN runs the higher net margin — LIVN at 12.82% versus RLAY at -2763.64%.
How have LIVN and RLAY total returns compared?: Over the past 5 years, LIVN delivered -1.66% and RLAY delivered -7.92% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LIVN analysis Full RLAY analysis Interactive comparison tool

Dig into the metrics

LivaNova P/E ratio LivaNova ROE Relay Therapeutics ROE LivaNova operating margin Relay Therapeutics operating margin LivaNova revenue growth Relay Therapeutics revenue growth LivaNova free cash flow Relay Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.